Evodiamine inhibits RANKL‐induced osteoclastogenesis and prevents ovariectomy‐induced bone loss in mice

Postmenopausal osteoporosis (PMO) is a progressive bone disease characterized by the over‐production and activation of osteoclasts in elderly women. In our study, we investigated the anti‐osteoclastogenic effect of evodiamine (EVO) in vivo and in vitro, as well as the underlying mechanism. By using...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Haiming, Yao, Lingya, Chen, Kai, Liu, Yuhao, Wang, Qingqing, Wang, Ziyi, Liu, Qian, Cao, Zhen, Kenny, Jacob, Tickner, Jennifer, Wang, Xiangyang, Xu, Jiake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307789/
https://www.ncbi.nlm.nih.gov/pubmed/30451360
http://dx.doi.org/10.1111/jcmm.13955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307789/
https://www.ncbi.nlm.nih.gov/pubmed/30451360
http://dx.doi.org/10.1111/jcmm.13955

Ejemplares similares